These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 15951177)
21. Congenital myasthenic syndromes. Engel AG; Ohno K Adv Neurol; 2002; 88():203-15. PubMed ID: 11908226 [No Abstract] [Full Text] [Related]
22. Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up. Durmus H; Shen XM; Serdaroglu-Oflazer P; Kara B; Parman-Gulsen Y; Ozdemir C; Brengman J; Deymeer F; Engel AG Neuromuscul Disord; 2018 Apr; 28(4):315-322. PubMed ID: 29395675 [TBL] [Abstract][Full Text] [Related]
23. Structural abnormalities of the AChR caused by mutations underlying congenital myasthenic syndromes. Beeson D; Webster R; Ealing J; Croxen R; Brownlow S; Brydson M; Newsom-Davis J; Slater C; Hatton C; Shelley C; Colquhoun D; Vincent A Ann N Y Acad Sci; 2003 Sep; 998():114-24. PubMed ID: 14592868 [TBL] [Abstract][Full Text] [Related]
24. Synaptic dysfunction in congenital myasthenic syndromes. Beeson D Ann N Y Acad Sci; 2012 Dec; 1275():63-9. PubMed ID: 23278579 [TBL] [Abstract][Full Text] [Related]
26. A mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia. Ben Ammar A; Soltanzadeh P; Bauché S; Richard P; Goillot E; Herbst R; Gaudon K; Huzé C; Schaeffer L; Yamanashi Y; Higuchi O; Taly A; Koenig J; Leroy JP; Hentati F; Najmabadi H; Kahrizi K; Ilkhani M; Fardeau M; Eymard B; Hantaï D PLoS One; 2013; 8(1):e53826. PubMed ID: 23326516 [TBL] [Abstract][Full Text] [Related]
27. Congenital myasthenic syndrome: Ten years clinical experience from a quaternary care south-Indian hospital. Wadwekar V; Nair SS; Tandon V; Kuruvilla A; Nair M J Clin Neurosci; 2020 Feb; 72():238-243. PubMed ID: 31889643 [TBL] [Abstract][Full Text] [Related]
28. Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients. Milone M; Shen XM; Selcen D; Ohno K; Brengman J; Iannaccone ST; Harper CM; Engel AG Neurology; 2009 Jul; 73(3):228-35. PubMed ID: 19620612 [TBL] [Abstract][Full Text] [Related]
29. A mouse model for congenital myasthenic syndrome due to MuSK mutations reveals defects in structure and function of neuromuscular junctions. Chevessier F; Girard E; Molgó J; Bartling S; Koenig J; Hantaï D; Witzemann V Hum Mol Genet; 2008 Nov; 17(22):3577-95. PubMed ID: 18718936 [TBL] [Abstract][Full Text] [Related]
38. Towards the molecular elucidation of congenital myasthenic syndromes: identification of mutations in MuSK. Chevessier F; Faraut B; Ravel-Chapuis A; Richard P; Gaudon K; Bauché S; Prioleau C; Herbst R; Goillot E; Ioos C; Azulay JP; Attarian S; Leroy JP; Fournier E; Legay C; Schaeffer L; Koenig J; Fardeau M; Eymard B; Pouget J; Hantaï D Acta Myol; 2005 Oct; 24(2):55-9. PubMed ID: 16550915 [TBL] [Abstract][Full Text] [Related]
39. Clinical and Genetic Features of Congenital Myasthenic Syndromes due to CHAT Mutations: Case Report and Literature Review. Arican P; Gencpinar P; Cavusoglu D; Olgac Dundar N Neuropediatrics; 2018 Aug; 49(4):283-288. PubMed ID: 29783273 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of salbutamol monotherapy in slow-channel congenital myasthenic syndrome caused by a novel mutation in CHRND. Tawara N; Yamashita S; Takamatsu K; Yamasaki Y; Mukaino A; Nakane S; Farshadyeganeh P; Ohno K; Ando Y Muscle Nerve; 2021 Apr; 63(4):E30-E32. PubMed ID: 33428214 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]